Effects of a betalain-rich concentrate on cycling performance and recovery
Official title: The Effects of an Acute Dose of a Betalain-rich Concentrate on Repeated-sprint Cycling Performance and Recovery: A Randomized, Double-blind, Crossover, Placebo-control Study.
Run by Drexel University · NCT06274385 · Data updated 2026-11-12
This study is testing if a betalain-rich drink can help active people perform better and recover faster after sprint cycling.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | Drexel University Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Status | Recruiting |
| Started | March 6, 2024 |
| Main results expected | June 2025 |
| Study ends | August 2025 |
| Registry record updated | November 22, 2024 |
| Trial ID | NCT06274385 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy, recreationally active males and females aged 18-40 without any musculoskeletal injuries or significant medical conditions.
✕Probably not a fit
Patients with existing musculoskeletal injuries or chronic medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the impact of a single acute dose of a betalain-rich concentrate (BRC) on repeated-sprint cycling performance and recovery in recreationally active individuals. A total of 10 participants will be recruited from the Drexel University student population and will undergo three laboratory visits, including a familiarization session and two testing sessions. Participants will be randomly assigned to receive either the BRC or a placebo, with performance metrics assessed through repeated-sprint exercises and recovery protocols.
Why it matters
Potential benefit: If successful, this study could enhance athletic performance and recovery for individuals engaged in high-intensity sports.
How similar studies have gone: Previous studies have shown promise for betalains as ergogenic aids, but this specific approach has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy, recreationally active males and females * Aged 18-40 * Free of disease or injury Exclusion Criteria: * Have any musculoskeletal injuries that could be made worse by participating in this study (e.g., sprain or strain of lower limb) * Have documented medical conditions (i.e., hypertension, asthma, heart disease, diabetes) or exhibit signs and symptoms of medical conditions * Taking any medication that would interfere with the interpretation of our results. These include, but are not limited to, anti-inflammatory drugs, antibiotics, anti-hypertensives, and any medicine controlling the digestive system.
Where it's running
-
Drexel University - Health Sciences Building
Philadelphia, Pennsylvania, United States Recruiting
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.